Whether your aim is to secure a supply chain, shorten turnaround times, control costs, protect intellectual property, or a combination of all these, setting up your own oligonucleotide synthesis facilities can be a successful solution for your lab.
However, numerous factors should be considered beyond simply choosing and purchasing an instrument. Download this helpful guide that walks you through key considerations to ensure the setup of oligo synthesis production is efficient and successful. Contents include:
- A helpful checklist for deciding whether to in-house or outsource
- Advice on instrumentation selection
- A list of required accessories and equipment
- Optimization tips for each step of the oligo synthesis cycle
- Considerations for successful set up of your lab; ventilation, waste management, reagent storage and more.
Download the full e-book
About LGC Biosearch Technologies
Together, we help you advance.
Whether you’re using marker-assisted selection to develop more nutritious and sustainable crops or developing the next generation of molecular diagnostic tests, clinical genomics assays, or novel oligo therapeutics, accurate and high-quality data is everything. And so is speed.
To help keep your mission-critical projects on target and moving quickly, LGC provides a large integrated portfolio of products and services to support your entire genomics workflow and help at every stage of your product development pipeline. From R&D through to large-scale commercialization, our products and services scale up when you do.
Watch the video to see how our unified genomics portfolio helps you discover more, speeding up your work to improve the human condition.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.